The Taylor Swift stock-market effect? We are -2-
'The market does not respond to pop stars.' Jeffrey Campbell, University of Notre Dame
Even if the naysayers are right that Swift isn't such a driving force in the economy -- or even a symbol of the spending we've seen in recent months -- that doesn't mean she hasn't changed the game in other ways, however. In terms of the music business alone, she's leaving an incredible imprint, say those who follow or work in the industry.
For years, there's been talk about how Live Nation Entertainment's (LYV) Ticketmaster subsidiary has done a poor job of serving fans and artists alike. But it took the Ticketmaster meltdown that resulted from Swift's "Eras Tour" going on sale to prompt a Senate hearing on the issue.
At that hearing, Live Nation President Joe Berchtold defended his company, saying, "Primary ticketing companies, including Ticketmaster, do not set ticket prices, do not decide how many tickets go on sale and when they go on sale, do not set service fees. Pricing and distribution strategies are determined by artists and teams."
Still, the damage could be done. Politico reported in July that the Justice Department may file an antitrust lawsuit against Live Nation and Ticketmaster. The Justice Department didn't respond to a MarketWatch request for comment.
Holly Gleason, a veteran, award-winning music journalist who's also worked in the industry, says Swift's role in the matter is undeniable. And her influence extends further, Gleason notes, pointing to how the singer is likely inspiring a generation of female entrepreneurs of all kinds.
"Whether you're a little girl who wants to start a business or write a song or publish a book ... whatever it is you want to do, she's the role model that says, 'Hell, yeah,' " Gleason says.
Swift also sends a message of another kind, says Damian Bazadona, founder of the Situation Group, a New York marketing agency that specializes in live entertainment.
Swift didn't amass a legion of fans for nothing, Bazadona explains. She did it by crafting hit after hit, from "Anti-Hero" to "We Are Never Ever Getting Back Together" to, yes, "Shake It Off."
Then, she stitched those songs together in a three-hour, 15-minute "Eras Tour" concert that even the most hardened of critics praised as a stunning summation of her life's work.
The inherent lesson is that you don't have Taylornomics without talent.
"You got to put on a good show," Bazadona concludes. "People will spend amazing money on a feeling worth feeling."
Indeed, the best news for the stock market may be that while the "Eras Tour" is done in the U.S. for 2023, it will resume in October 2024, starting with Swift's performance in Miami. Meanwhile, Swift is continuing the international leg of her tour in Argentina next month, having already played Mexico in August.
For her part, Mahon, the New Jersey fan who already spent $10,000 attending Swift concerts, is looking to keep the party going. She's already made plans to attend the "Eras Tour" stop in Vienna next summer and may add the tour's closing European date in London as part of the same sojourn, leaving time for some sightseeing along the way.
"I do want to make a trip out of it," Mahon says.
-Charles Passy
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
11-04-23 1319ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom
-
Albemarle Earnings: We Expect Improved Results In the Rest of Year Following Cyclically Low Profits